As the Director of the Pharmacy Special Investigations Unit (SIU) at Express Scripts, Michael Klein plays a pivotal role in safeguarding the integrity of pharmaceutical services against fraud, waste, and abuse (FWA). With a robust background in law enforcement partnerships and fraud strategy development, Michael...
As the Director of the Pharmacy Special Investigations Unit (SIU) at Express Scripts, Michael Klein plays a pivotal role in safeguarding the integrity of pharmaceutical services against fraud, waste, and abuse (FWA). With a robust background in law enforcement partnerships and fraud strategy development, Michael leads the charge in implementing complex oversight integrations for new clients, ensuring compliance with stringent regulatory guidelines. His expertise is particularly valuable when managing large-scale client implementations, where he navigates the intricacies of contracts and audit guidelines to proactively mitigate risks associated with FWA.
Under Michael's leadership, the SIU has successfully recovered incremental funds exceeding $50 million in 2020 alone, underscoring his commitment to driving change and enhancing operational efficiency. His strategic planning and business process improvement skills enable him to design and implement innovative technology solutions that streamline investigations and bolster security measures. Michael’s proficiency in vendor management and team building fosters a collaborative environment, empowering his team to tackle challenges head-on and achieve measurable results.
In an industry where compliance and risk management are paramount, Michael Klein’s contributions are invaluable. He continuously seeks to refine internal procedures and external contracts, ensuring that Express Scripts remains at the forefront of fraud prevention. With a keen eye for detail and a results-driven approach, Michael is not only a leader but also a visionary in the fight against healthcare fraud, making significant strides in protecting both clients and patients alike.
